Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. 2009

Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.

Interferons (IFNs) and the interferon-stimulated genes (ISGs) play a central role in antiviral responses against hepatitis C virus (HCV) infection. We have reported previously that ISGs, including guanylate binding protein 1 (GBP-1), interferon alpha inducible protein (IFI)-6-16, and IFI-27, inhibit HCV subgenomic replication. In this study we investigated the effects of these ISGs against HCV in cell culture and their direct molecular interaction with viral proteins. HCV replication and virus production were suppressed significantly by overexpression of GBP-1, IFI-6-16, or IFI-27. Knockdown of the individual ISGs enhanced HCV RNA replication markedly. A two-hybrid panel of molecular interaction of the ISGs with HCV proteins showed that GBP-1 bound HCV-NS5B directly. A protein truncation assay showed that the guanine binding domain of GBP-1 and the finger domain of NS5B were involved in the interaction. Binding of NS5B with GBP-1 inhibited its guanosine triphosphatase GTPase activity, which is essential for its antiviral effect. Taken together, interferon-induced GBP-1 showed antiviral activity against HCV replication. CONCLUSIONS Binding of the HCV-NS5B protein to GBP-1 countered the antiviral effect by inhibition of its GTPase activity. These mechanisms may contribute to resistance to innate, IFN-mediated antiviral defense and to the clinical persistence of HCV infection.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000251 Adenosine Triphosphatases A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA. ATPases,Adenosinetriphosphatase,ATPase,ATPase, DNA-Dependent,Adenosine Triphosphatase,DNA-Dependent ATPase,DNA-Dependent Adenosinetriphosphatases,ATPase, DNA Dependent,Adenosinetriphosphatases, DNA-Dependent,DNA Dependent ATPase,DNA Dependent Adenosinetriphosphatases,Triphosphatase, Adenosine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory

Related Publications

Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
March 1999, Virology,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
May 2016, Journal of virology,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
January 2000, Journal of molecular medicine (Berlin, Germany),
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
April 1999, Hepatology (Baltimore, Md.),
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
February 2003, The Journal of biological chemistry,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
January 2005, The Journal of infectious diseases,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
March 2004, Journal of virology,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
November 2007, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
June 2008, FEBS letters,
Yasuhiro Itsui, and Naoya Sakamoto, and Sei Kakinuma, and Mina Nakagawa, and Yuko Sekine-Osajima, and Megumi Tasaka-Fujita, and Yuki Nishimura-Sakurai, and Gouki Suda, and Yuko Karakama, and Kako Mishima, and Machi Yamamoto, and Takako Watanabe, and Mayumi Ueyama, and Yusuke Funaoka, and Seishin Azuma, and Mamoru Watanabe
June 2007, Journal of biochemistry,
Copied contents to your clipboard!